1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RP11-529K1.3 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA TTC25 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA MARK4 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA SH3GLB1 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA MTMR8 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA WHSC1L1 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA MTNR1A CTRPv2 pan-cancer AAC 0.088 0.02
mRNA FAM72D CTRPv2 pan-cancer AAC -0.11 0.02
mRNA OR11H6 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA PI3 CTRPv2 pan-cancer AAC 0.091 0.02
Download CSV